RdESAT-6 / rCFP-10 (1) – Siiltibcy®

Other diagnostic agents

Characteristics

Start date 29.08.2025
Resolution 16.10.2025
INN RdESAT-6 /rCFP-10
Brand name Siiltibcy®
Pharm. company Serum Life Science Europe GmbH
G-BA Procedure ID F-003
Therapeutic area Infectious diseases
Reason for procedure not completed: exempted

Associated procedures

RdESAT-6 / rCFP-10 (1) Siiltibcy® Serum Life Science Europe GmbH Infectious diseases Other diagnostic agents n.d. exempted


<< List of all resolutions